Hextan S. Ngan
Distinguished in Hydatidiform Mole

Hextan S. Ngan

6/F Professorial Block, 102 Pokfulam Road, 
Hong Kong, HCW, HK 
Distinguished in Hydatidiform Mole
6/F Professorial Block, 102 Pokfulam Road, 
Hong Kong, HCW, HK 
OverviewLocationsClinical Research

Overview

Hextan Ngan practices in Hong Kong, Hong Kong Special Administrative Region. Ms. Ngan is rated as a Distinguished expert by MediFind in the treatment of Hydatidiform Mole. Her top areas of expertise are Trophoblastic Tumor Placental Site, Hydatidiform Mole, Gestational Trophoblastic Disease, Hysterectomy, and Endoscopy.

Her clinical research consists of co-authoring 183 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 13 articles in the study of Hydatidiform Mole.

Gender
Female

Locations

6/F Professorial Block, 102 Pokfulam Road, Hong Kong, HCW, Hong Kong Special Administrative Region
Other Locations
Room 406, Pokfulam Road, Hong Kong, HCW, Hong Kong Special Administrative Region
Pokfulam Road, Hong Kong, HCW, Hong Kong Special Administrative Region

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

The Use of a New Biomarker, HE4, in Combination With Simple Ultrasound Rules in the Prediction of Malignancy in a Pelvic Mass Detected on Ultrasound
The Use of a New Biomarker, HE4, in Combination With Simple Ultrasound Rules in the Prediction of Malignancy in a Pelvic Mass Detected on Ultrasound
Enrollment Status: Unknown
Publish Date: June 11, 2021

183 Total Publications

Author Correction: Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.
Author Correction: Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells.
Journal: Communications biology
Published: February 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Ngan's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile